Equities

Celularity Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CELU:NAQ

Celularity Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.27
  • Today's Change0.035 / 2.85%
  • Shares traded15.10k
  • 1 Year change-38.29%
  • Beta0.7804
Data delayed at least 15 minutes, as of Feb 13 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, Celularity Inc increased its cash reserves by 8.01%, or 814.00k. Cash Flow from Financing totalled 6.70m or 12.36% of revenues. In addition the company used 6.40m for operations while cash from investing totalled 514.00k.
Cash flow per share-3.05
Price/Cash flow per share--
Book value per share-0.7121
Tangible book value per share-1.26
More ▼

Balance sheet in USDView more

Celularity Inc has a Debt to Total Capital ratio of 201.17%.
Current ratio0.1622
Quick ratio0.123
Total debt/total equity--
Total debt/total capital2.01
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.